FBPase-1 inhibitor-1
FBPase-1 inhibitor-1 (compound 1) is a allosteric inhibitor of fructose-1,6-bisphosphatase (FBPase-1) [1].
Product Specifications
CAS Number
[883973-99-7]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
FBPase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fbpase-1-inhibitor-1.html
Concentration
10mM
Purity
99.10
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S(C1=CC(Cl)=CC=C1Cl)(NC2=NC3=CC(Cl)=CC=C3O2)=O
Molecular Formula
C13H7Cl3N2O3S
Molecular Weight
377.63
Precautions
H315, H319, H335
References & Citations
[1]Thomas W von Geldern, et al. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode. Bioorg Med Chem Lett. 2006 Apr 1;16 (7) :1811-5.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
016277 10 mg
1- (4-O-Methoxymethyl-4-hydroxyphenyl) -4- (4-nitrophenyl) piperazine-d4
Sign In for Pricing
View Details 
K1858707 1.0 µg DNA
RNU7-42P sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details N2150-01E 50 µg
Neurofibromin, Control Peptide, Human (NF1, WSS, NFNS, VRNF, NF, Neurofibromin 1, neurofibromatosis, type I, von Recklinghausen disease neurofibromin, Neurofibromatosis-Noonan syndrome, WATS, Watson Syndrome) discontinued
Sign In for Pricing
View Details